Contact Us

epiOpioid

Coming soon: epiOpioid is our innovative test that targets the OPRM1 receptor's methylation patterns to assess your epigenetic predisposition to opioid addiction. High methylation in the region that we examine is associated with opioid dependence. It offers a whole new dimension in personalized addiction management and prevention.

Enter your info if you are interested in learning more and someone will be in touch.

epiOpioid: Assess Genetic Predisposition to Opioid Addition

epiOpioid is our innovative test that targets the OPRM1 receptor’s methylation patterns to assess your epigenetic predisposition to opioid addiction. High methylation in the region that we examine is associated with opioid dependence. It offers a whole new dimension in personalized addiction management and prevention.

[This page is still under development]

No instructions available.

Reviews

There are no reviews yet.

Be the first to review “epiOpioid”

Your email address will not be published. Required fields are marked *

Address

EpiMedTechGlobal (EMTG)
60 Paya Lebar Road, #08-06 Paya Lebar Square
Singapore 409051

Honk Kong Lab
Unit 313-315, 3/F Biotech Centre 2
11 Science Park West Avenue
Hong Kong Science Park

US Epitherapeutics
1829 Reisterstown Rd, Suite: 350 Baltimore, MD 21208
+1 (443) 256 5179
MTL Epitherapeutics
600 – 2000 AV McGill College Montreal, QC CA H3A3H3
+1 (514) 448 2185
Shenzhen Lab
Zone E, Floor 4, Building E, Gangzhilong Business Center,
Qinglong Road, Longhua District, Shenzhen

Email Us

info@hkgepitherapeutics.com

Call Us On

Hong Kong: +(852) 60725262 USA: +1 (443) 256 5179 Canada: +1 (514) 448 2185

Founded in 2016 by Prof. Moshe Szyf, a global pioneer in the dynamic and rapidly evolving field of epigenetics, EpiMedTechGlobal (EMTG) stands as a force driving innovation. Officially headquartered in Singapore, our organization directs a state-of-the-art research and diagnostic lab located in Hong Kong, which serves as the epicenter of our groundbreaking endeavors. Here, our dedicated scientists are committed to driving innovation in epigenetics and the early detection of diseases. At EMTG, it’s not just about detecting diseases; it’s about unlocking and offering solutions that promote longevity through the hidden stories in our DNA.

Read More

Useful Links

Recent Posts

©2023, EpiMedTechGlobal. All Rights Reserved.

Follow Us :
Scroll to Top